Institutional & Family Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $89K | Sell |
384
-36
| -9% | -$7.82K | 0.01% | 196 |
|
|
2024
Q1 | $90.6K | Sell |
420
-11
| -3% | -$2.58K | 0.01% | 195 |
|
|
2023
Q4 | $112K | Buy |
431
+1
| +0.2% | +$246 | 0.02% | 179 |
|
|
2023
Q3 | $111K | Buy |
430
+29
| +7% | +$7.76K | 0.02% | 169 |
|
|
2023
Q2 | $114K | Sell |
401
-3
| -0.7% | -$893 | 0.02% | 171 |
|
|
2023
Q1 | $112K | Sell |
404
-22
| -5% | -$6.09K | 0.02% | 167 |
|
|
2022
Q4 | $118K | Sell |
426
-9
| -2% | -$2.54K | 0.02% | 157 |
|
|
2022
Q3 | $116K | Sell |
435
-5
| -1% | -$1.06K | 0.02% | 159 |
|
|
2022
Q2 | $90K | Sell |
440
-15
| -3% | -$3.07K | 0.02% | 179 |
|
|
2022
Q1 | $96K | Sell |
455
-16
| -3% | -$3.48K | 0.02% | 193 |
|
|
2021
Q4 | $113K | Sell |
471
-75
| -14% | -$19.3K | 0.02% | 195 |
|
|
2021
Q3 | $155K | Hold |
546
| – | – | 0.02% | 199 |
|
|
2021
Q2 | $189K | Buy |
546
+26
| +5% | +$7.88K | 0.03% | 180 |
|
|
2021
Q1 | $145K | Buy |
520
+4
| +0.8% | +$1.08K | 0.03% | 221 |
|
|
2020
Q4 | $126K | Hold |
516
| – | – | 0.03% | 226 |
|
|
2020
Q3 | $146K | Hold |
516
| – | – | 0.03% | 196 |
|
|
2020
Q2 | $138K | Sell |
516
-6
| -1% | -$1.8K | 0.03% | 204 |
|
|
2020
Q1 | $165K | Sell |
522
-15
| -3% | -$4.55K | 0.04% | 164 |
|
|
2019
Q4 | $159K | Sell |
537
-6
| -1% | -$1.67K | 0.03% | 189 |
|
|
2019
Q3 | $126K | Buy |
543
+37
| +7% | +$8.62K | 0.03% | 196 |
|
|
2019
Q2 | $118K | Sell |
506
-832
| -62% | -$192K | 0.03% | 209 |
|
|
2019
Q1 | $316K | Sell |
1,338
-33
| -2% | -$10.4K | 0.07% | 149 |
|
|
2018
Q4 | $413K | Sell |
1,371
-6
| -0.4% | -$1.92K | 0.09% | 117 |
|
|
2018
Q3 | $487K | Sell |
1,377
-5
| -0.4% | -$1.72K | 0.1% | 117 |
|
|
2018
Q2 | $401K | Sell |
1,382
-819
| -37% | -$230K | 0.08% | 126 |
|
|
2018
Q1 | $603K | Sell |
2,201
-13
| -0.6% | -$4.04K | 0.13% | 99 |
|
|
2017
Q4 | $705K | Sell |
2,214
-96
| -4% | -$30.8K | 0.14% | 94 |
|
|
2017
Q3 | $723K | Buy |
2,310
+384
| +20% | +$114K | 0.15% | 101 |
|
|
2017
Q2 | $523K | Sell |
1,926
-12
| -0.6% | -$3.17K | 0.13% | 90 |
|
|
2017
Q1 | $530K | Buy |
1,938
+1
| +0.1% | +$283 | 0.17% | 91 |
|
|
2016
Q4 | $549K | Sell |
1,937
-85
| -4% | -$25.2K | 0.17% | 92 |
|
|
2016
Q3 | $633K | Sell |
2,022
-972
| -32% | -$288K | 0.21% | 81 |
|
|
2016
Q2 | $724K | Sell |
2,994
-1,971
| -40% | -$519K | 0.25% | 79 |
|
|
2016
Q1 | $1.52M | Hold |
4,965
| – | – | 0.57% | 71 |
|
|
2015
Q4 | $1.52M | Buy |
+4,965
| New | +$1.43M | 0.57% | 71 |
|
Other funds holding BIIB
Institutional & Family Asset Management's BIIB Position: Q2 2024 in Review
Institutional & Family Asset Management reduced its Biogen (BIIB) stake by 8.6% in Q2 2024, selling an estimated $7.82K and leaving 384 shares worth $89K. The position accounts for 0.01% of the portfolio, ranked #196.
Institutional & Family Asset Management first reported a position in BIIB in Q4 2015 and has held it in 35 quarters since. The position peaked at $1.52M in Q1 2016. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.
- Institutional & Family Asset Management held 384 shares of Biogen worth $89K as of Q2 2024.
- Institutional & Family Asset Management sold 36 Biogen shares in Q2 2024, an estimated $7.82K.
- Biogen made up 0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #196 holding.
- Institutional & Family Asset Management first reported a position in Biogen in Q4 2015 and has held it in 35 quarters since.
- Institutional & Family Asset Management's Biogen position peaked at $1.52M in Q1 2016.
- 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.
Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.